ALDEYRA THERAPEUTICS, INC. Line of Credit Facility, Interest Rate During Period
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Line of Credit Facility, Interest Rate During Period of 9.10% for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityInterestRateDuringPeriod · last filed 2020-11-05
- 2020-09-30: .
- 2020-06-30: Line of Credit Facility, Interest Rate During Period 6 month 9.10%.
- 2015-11-30: Line of Credit Facility, Interest Rate During Period 1 month 6.50%.
- 2013-11-30: Line of Credit Facility, Interest Rate During Period 1 month 6.50%.
| Period end | Line of Credit Facility, Interest Rate During Period 0 month | Line of Credit Facility, Interest Rate During Period | Line of Credit Facility, Interest Rate During Period 1 month | Line of Credit Facility, Interest Rate During Period 6 month | Line of Credit Facility, Interest Rate During Period 9 month |
|---|---|---|---|---|---|
| 2020-09-30 | 9.10% 10-Q · filed 2020-11-05 | ||||
| 2020-06-30 | 9.10% 10-Q · filed 2020-08-06 | ||||
| 2015-11-30 | 6.50% 10-Q · filed 2016-11-14 | ||||
| 2013-11-30 | 6.50% 10-K · filed 2015-03-23 | ||||
| 2013-11-20 | 6.50% 10-Q · filed 2014-06-11 | 6.50% 10-Q · filed 2014-11-12 | |||
| 2012-04-12 | 6.50% 10-Q · filed 2014-06-11 | 6.50% 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |